Macrocycles as Factor XIa inhibitors

Details for Australian Patent Application No. 2011215898 (hide)

Owner Bristol-Myers Squibb Company

Inventors Corte, James R.; Fang, Tianan; Decicco, Carl P.; Pinto, Donald J. P.; Rossi, Karen A.; Hu, Zilun; Jeon, Yoon; Quan, Mimi L.; Smallheer, Joanne M.; Wang, Yufeng; Yang, Wu

Agent A J Park

Pub. Number AU-A-2011215898

PCT Pub. Number WO2011/100401

Priority 61/405,338 21.10.10 US; 61/303,423 11.02.10 US

Filing date 10 February 2011

Wipo publication date 18 August 2011

International Classifications

C07D 487/08 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 498/08 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

27 September 2012 PCT application entered the National Phase

  PCT publication WO2011/100401 Priority application(s): WO2011/100401

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011215900-CD20 antibodies and uses thereof

2011215890-Method and apparatus for in vitro testing for medical devices